Constitutive expression of B7-1 on B cells uncovers autoimmunity toward the B cell compartment in the nonobese diabetic mouse

Journal of Immunology

Volumn 179, Issue 2, 2007, Pages 1004-1012

  Bour Jordan, Hélène ^a   Salomon, Benoit L ^b   Thompson, Heather L ^a   Santos, Rex ^a   Abbas, Abul K ^a   Bluestone, Jeffrey A ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CNRS   (France)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; AUTOANTIGEN; CD28 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL COMPARTMENTALIZATION; CELL SPECIFICITY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENETICS; INSULITIS; MALE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; SPLEEN; TRANSGENIC MOUSE; ADOPTIVE TRANSFER; ANIMAL; CYTOLOGY; FLOW CYTOMETRY; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; METABOLISM; T LYMPHOCYTE;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD28; ANTIGENS, CD80; AUTOANTIGENS; AUTOIMMUNITY; B-LYMPHOCYTES; DIABETES MELLITUS, TYPE 1; FLOW CYTOMETRY; MICE; MICE, INBRED NOD; MICE, TRANSGENIC; SPLEEN; T-LYMPHOCYTES;

EID: 34548774646     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.2.1004     Document Type: Article

References (57)

1. Bach, J. F. 1994. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr. Rev. 15: 516-542.
2. Kikutani, H., and S. Makino. 1992. The murine autoimmune diabetes model: NOD and related strains. Adv. Immunol. 51: 285-322.
3. Salomon, B., L. Rhee, H. Bour-Jordan, H. Hsin, A. Montag, B. Soliven, J. Arcella, A. M. Girvin, S. D. Miller, and J. A. Bluestone. 2001. Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice. J. Exp. Med. 194: 677-684.
4. + regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J. Exp. Med. 201: 723-735.
5. Hu, Y., Y. Nakagawa, K. R. Purushotham, and M. G. Humphreys-Beher. 1992. Functional changes in salivary glands of autoimmune disease-prone NOD mice. Am. J. Physiol. 263: E607-E614.
6. Many, M. C., S. Maniratunga, and J. F. Denef. 1996. The non-obese diabetic (NOD) mouse: an animal model for autoimmune thyroiditis. Exp. Clin. Endocrinol. Diabetes 104(Suppl. 3): 17-20.
7. Rivero, V. E., C. Cailleau, M. Depiante-Depaoli, C. M. Riera, and C. Carnaud. 1998. Non-obese diabetic (NOD) mice are genetically susceptible to experimental autoimmune prostatitis (EAP). J. Autoimmun. 11: 603-610.
8. Baxter, A. G., A. C. Horsfall, D. Healey, P. Ozegbe, S. Day, D. G. Williams, and A. Cooke. 1994. Mycobacteria precipitate an SLE-like syndrome in diabetes-prone NOD mice. Immunology 83: 227-231.
9. Oldenborg, P. A., H. D. Gresham, Y. Chen, S. Izui, and F. P. Lindberg. 2002. Lethal autoimmune hemolytic anemia in CD47-deficient nonobese diabetic (NOD) mice. Blood 99: 3500-3504.
10. Robinson, C. P., S. Yamachika, D. I. Bounous, J. Brayer, R. Jonsson, R. Holmdahl, A. B. Peck, and M. G. Humphreys-Beher. 1998. A novel NOD-derived murine model of primary Sjogren's syndrome. Arthritis Rheum. 41: 150-156.
11. Girvin, A. M., M. C. Dal Canto, L. Rhee, B. Salomon, A. Sharpe, J. A. Bluestone, and S. D. Miller. 2000. A critical role for B7/CD28 costimulation in experimental autoimmune encephalomyelitis: a comparative study using costimulatory molecule-deficient mice and monoclonal antibody blockade. J. Immunol. 164: 136-143.
12. Lenschow, D. J., T. L. Walunas, and J. A. Bluestone. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14: 233-258.
13. Salomon, B., and J. A. Bluestone. 2001. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu. Rev. Immunol. 19: 225-252.
14. Bour-Jordan, H., and J. A. Bluestone. 2002. CD28 function: a balance of costimulatory and regulatory signals. J. Clin. Immunol. 22: 1-7.
15. + immunoregulatory T cells that control autoimmune diabetes. Immunity 12: 431-440.
16. Lenschow, D. J., S. C. Ho, H. Sattar, L. Rhee, G. Gray, N. Nabavi, K. C. Herold, and J. A. Bluestone. 1995. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 181: 1145-1155.
17. Bour-Jordan, H., B. L. Salomon, H. L. Thompson, G. L. Szot, M. R. Bernhard, and J. A. Bluestone. 2004. Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells. J. Clin. Invest. 114: 979-987.
18. Anderson, M. S., and J. A. Bluestone. 2005. The NOD mouse: a model of immune dysregulation. Annu. Rev. Immunol. 23: 447-485.
19. Makino, S., K. Kunimoto, Y. Muraoka, Y. Mizushima, K. Katagiri, and Y. Tochino. 1980. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 29: 1-13.
20. + T cells. J. Exp. Med. 166: 823-832.
21. Haskins, K., and D. Wegmann. 1996. Diabetogenic T-cell clones. Diabetes 45: 1299-1305.
22. Wong, F. S., I. Visintin, L. Wen, R. A. Flavell, and C. A. Janeway, Jr. 1996. CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. J. Exp. Med. 183: 67-76.
23. Yu, L., D. T. Robles, N. Abiru, P. Kaur, M. Rewers, K. Kelemen, and G. S. Eisenbarth. 2000. Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. Proc. Natl. Acad. Sci. USA 97: 1701-1706.
24. Akashi, T., S. Nagafuchi, K. Anzai, S. Kondo, D. Kitamura, S. Wakana, J. Ono, M. Kikuchi, Y. Niho, and T. Watanabe. 1997. Direct evidence for the contribution of B cells to the progression of insulitis and the development of diabetes in non-obese diabetic mice. Int. Immunol. 9: 1159-1164.
25. Yang, M., B. Charlton, and A. M. Gautam. 1997. Development of insulitis and diabetes in B cell-deficient NOD mice. J. Autoimmun. 10: 257-260.
26. Noorchashm, H., N. Noorchashm, J. Kern, S. Y. Rostami, C. F. Barker, and A. Naji. 1997. B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice. Diabetes 46: 941-946.
27. Serreze, D. V., H. D. Chapman, D. S. Varnum, M. S. Hanson, P. C. Reifsnyder, S. D. Richard, S. A. Fleming, E. H. Leiter, and L. D. Shultz. 1996. B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig μ null mice. J. Exp. Med. 184: 2049-2053.
28. Falcone, M., J. Lee, G. Patstone, B. Yeung, and N. Sarvetnick. 1998. B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice. J. Immunol. 161: 1163-1168.
29. Noorchashm, H., Y. K. Lieu, N. Noorchashm, S. Y. Rostami, S. A. Greeley, A. Schlachterman, H. K. Song, L. E. Noto, A. M. Jevnikar, C. F. Barker, and A. Naji. 1999. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet β cells of nonobese diabetic mice. J. Immunol. 163: 743-750.
30. Wong, F. S., L. Wen, M. Tang, M. Ramanathan, I. Visintin, J. Daugherty, L. G. Hannum, C. A. Janeway, Jr., and M. J. Shlomchik. 2004. Investigation of the role of B-cells in type 1 diabetes in the NOD mouse. Diabetes 53: 2581-2587.
31. Silveira, P. A., E. Johnson, H. D. Chapman, T. Bui, R. M. Tisch, and D. V. Serreze. 2002. The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptors. Eur. J. Immunol. 32: 3657-3666.
32. Sethna, M. P., L. van Parijs, A. H. Sharpe, A. K. Abbas, and G. J. Freeman. 1994. A negative regulatory function of B7 revealed in B7-1 transgenic mice. Immunity 1: 415-421.
33. Van Parijs, L., M. P. Sethna, A. N. Schweitzer, F. Borriello, A. H. Sharpe, and A. K. Abbas. 1997. Functional consequences of dysregulated B7-1 (CD80) and B7-2 (CD86) expression in B or T lymphocytes of transgenic mice. J. Immunol. 159: 5336-5344.
34. Lenschow, D. J., K. C. Herold, L. Rhee, B. Patel, A. Koons, H. Y. Qin, E. Fuchs, B. Singh, C. B. Thompson, and J. A. Bluestone. 1996. CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. Immunity 5: 285-293.
35. Szot, G. L., P. Zhou, I. Rulifson, J. Wang, Z. Guo, O. Kim, K. A. Newel, J. R. Thistlethwaite, J. A. Bluestone, and M. L. Alegre. 2001. Different mechanisms of cardiac allograft rejection in wildtype and CD28-deficient mice. Am. J. Transplant. 1: 38-46.
36. Lanzavecchia, A. 1985. Antigen-specific interaction between T and B cells. Nature 314: 537-539.
37. Greeley, S. A., M. Katsumata, L. Yu, G. S. Eisenbarth, D. J. Moore, H. Goodarzi, C. F. Barker, A. Naji, and H. Noorchashm. 2002. Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice. Nat. Med. 8: 399-402.
38. Serreze, D. V., S. A. Fleming, H. D. Chapman, S. D. Richard, E. H. Leiter, and R. M. Tisch. 1998. B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. J. Immunol. 161: 3912-3918.
39. Noorchashm, H., D. J. Moore, L. E. Noto, N. Noorchashm, A. J. Reed, A. L. Reed, H. K. Song, R. Mozaffari, A. M. Jevnikar, C. F. Barker, and A. Naji. 2000. Impaired CD4 T cell activation due to reliance upon B cell-mediated costimulation in nonobese diabetic (NOD) mice. J. Immunol. 165: 4685-4696.
40. Martin, F., and J. F. Kearney. 2000. B-cell subsets and the mature preimmune repertoire: marginal zone and B1 B cells as part of a "natural immune memory." Immunol. Rev. 175: 70-79.
41. Pillai, S., A. Cariappa, and S. T. Moran. 2005. Marginal zone B cells. Annu. Rev. Immunol. 23: 161-196.
42. Martin, F., A. M. Oliver, and J. F. Kearney. 2001. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 14: 617-629.
43. -/- mice. J. Exp. Med. 194: 1141-1150.
44. Hao, Z., and K. Rajewsky. 2001. Homeostasis of peripheral B cells in the absence of B cell influx from the bone marrow. J. Exp. Med. 194: 1151-1164.
45. Cabatingan, M. S., M. R. Schmidt, R. Sen, and R. T. Woodland. 2002. Naive B lymphocytes undergo homeostatic proliferation in response to B cell deficit. J. Immunol. 169: 6795-6805.
46. high B lymphocytes in nonobese diabetic mice maps to diabetes susceptibility region Idd11. J. Immunol. 174: 4821-4827.
47. Fournier, S., J. C. Rathmell, C. C. Goodnow, and J. P. Allison. 1997. T cell-mediated elimination of B7.2 transgenic B cells. Immunity 6: 327-339.
48. Hardy, R. R., and K. Hayakawa. 2001. B cell development pathways. Annu. Rev. Immunol. 19: 595-621.
49. Pillai, S., A. Cariappa, and S. T. Moran. 2004. Positive selection and lineage commitment during peripheral B-lymphocyte development. Immunol. Rev. 197: 206-218.
50. Acevedo-Suarez, C. A., C. Hulbert, E. J. Woodward, and J. W. Thomas. 2005. Uncoupling of anergy from developmental arrest in anti-insulin B cells supports the development of autoimmune diabetes. J. Immunol. 174: 827-833.
51. Hulbert, C., B. Riseili, M. Rojas, and J. W. Thomas. 2001. B cell specificity contributes to the outcome of diabetes in nonobese diabetic mice. J. Immunol. 167: 5535-5538.
52. Silveira, P. A., J. Dombrowsky, E. Johnson, H. D. Chapman, D. Nemazee, and D. V. Serreze. 2004. B cell selection defects underlie the development of diabetogenic APCs in nonobese diabetic mice. J. Immunol. 172: 5086-5094.
53. Thomas, J. W., P. L. Kendall, and H. G. Mitchell. 2002. The natural autoantibody repertoire of nonobese diabetic mice is highly active. J. Immunol. 169: 6617-6624.
54. Quinn, W. J., III, N. Noorchashm, J. E. Crowley, A. J. Reed, H. Noorchashm, A. Naji, and M. P. Cancro. 2006. Cutting edge: impaired transitional B cell production and selection in the nonobese diabetic mouse. J. Immunol. 176: 7159-7164.
55. Tian, J., D. Zekzer, Y. Lu, H. Dang, and D. L. Kaufman. 2006. B cells are crucial for determinant spreading of T cell autoimmunity among β cell antigens in diabetes-prone nonobese diabetic mice. J. Immunol. 176: 2654-2661.
56. Miller, S. D., C. L. Vanderlugt, D. J. Lenschow, J. G. Pope, N. J. Karandikar, M. C. Dal Canto, and J. A. Bluestone. 1995. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity 3: 739-745.
57. Vanderlugt, C. L., K. L. Neville, K. M. Nikcevich, T. N. Eagar, J. A. Bluestone, and S. D. Miller. 2000. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis. J. Immunol. 164: 670-678.